XML 22 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Treasury stock (in shares)           0
Balance at beginning of year (in shares) at Jan. 01, 2022   223,000,000.0        
Balance at beginning of year at Jan. 01, 2022 $ 3,735 $ 2 $ 2,970 $ 782 $ (19) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation expense 45   45      
Proceeds from employee share purchase plan (in shares)   800,000        
Proceeds from employee stock purchase plan 22   22      
Vested restricted stock units, net, shares   800,000        
Vested restricted stock units, net 0   0      
Exercise of stock options (in shares)   600,000        
Stock Issued During Period, Value, Stock Options Exercised 15   15      
Tax withholding payments for net share-settled equity awards (16)   (16)      
Series A convertible preferred stock dividends (37)     (37)    
Changes in retirement benefit obligations, net of income tax (54)       (54)  
Common stock repurchased           400,000
Common stock repurchased (14)         $ (14)
Net income 265     265    
Shares, Outstanding, Ending Balance at Dec. 31, 2022   225,200,000        
Balance at end of year at Dec. 31, 2022 3,961 $ 2 3,036 1,010 (73) $ (14)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Treasury stock (in shares)           400,000
Share-based compensation expense 56   56      
Proceeds from employee share purchase plan (in shares)   700,000        
Proceeds from employee stock purchase plan 24   24      
Vested restricted stock units, net, shares   800,000        
Vested restricted stock units, net 0          
Exercise of stock options (in shares)   1,200,000        
Stock Issued During Period, Value, Stock Options Exercised 25   25      
Tax withholding payments for net share-settled equity awards (12)   (12)      
Series A convertible preferred stock conversion to common stock (in shares)   25,000,000.0        
Series A convertible preferred stock conversion to common stock 535 $ 1 534      
Series A convertible preferred stock dividends (7)     (7)    
Changes in retirement benefit obligations, net of income tax (43)       (43)  
Amount of Gain Reclassified from Accumulated Other Comprehensive Loss to Income, net of tax 1       1  
Common stock repurchased           7,400,000
Common stock repurchased (294)         $ (294)
Excise tax on common stock repurchases (3)         (3)
Net income $ 506     506    
Shares, Outstanding, Ending Balance at Dec. 30, 2023 245,100,000 252,900,000        
Balance at end of year at Dec. 30, 2023 $ 4,749 $ 3 3,663 1,509 (115) $ (311)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Treasury stock (in shares) 7,800,000         7,800,000
Share-based compensation expense $ 63   63      
Proceeds from employee share purchase plan (in shares)   400,000        
Proceeds from employee stock purchase plan 28   28      
Vested restricted stock units, net, shares   700,000        
Vested restricted stock units, net $ 0          
Exercise of stock options (in shares) 807,145 700,000        
Stock Issued During Period, Value, Stock Options Exercised $ 15   15      
Tax withholding payments for net share-settled equity awards (21)   (21)      
Changes in retirement benefit obligations, net of income tax 158       158  
Common stock repurchased           16,400,000
Common stock repurchased (958)         $ (958)
Excise tax on common stock repurchases (10)          
Net income $ 494     494    
Shares, Outstanding, Ending Balance at Dec. 28, 2024 230,500,000 254,700,000        
Balance at end of year at Dec. 28, 2024 $ 4,528 $ 3 $ 3,748 $ 2,003 $ 43 $ (1,269)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Treasury stock (in shares) 24,200,000         24,200,000